Archive · 24 Sep 2025
New FDA-Approved Alzheimer's Test Now Available in India
A new, easy test for Alzheimer's is now available in India!
It starts with a short quiz on your phone or computer to check your brain function.
If the quiz shows signs of a problem, a blood test is done to look for proteins linked to Alzheimer's.
The test is approved by the FDA and has shown to be 90% effective.
This new test is non-invasive, unlike the older method of a spinal tap.
This can help doctors diagnose Alzheimer’s earlier.
A new non-invasive Alzheimer's test, Dendrite Dx, is now available in India.
The test includes a cognitive quiz and blood-based biomarker analysis.
It is intended for individuals with cognitive decline symptoms or risk factors.
The test has an efficacy score of 90 percent.
It is a series of tests expected to cost approximately Rs 10,000.
- Who
- Individuals showing cognitive decline
- What
- A new non-invasive test to detect Alzheimer's disease
- When
- Now available
- Where
- India
- Why
- To increase accessibility and aid early detection of Alzheimer's
- Test Name
- Dendrite Dx
- Type
- Non-invasive
- Approval
- USFDA
- Includes
- Cognitive Quiz and Blood Tests
- Efficacy
- 90%
- Price (Estimated)
- Rs 10,000